Zevia Announces Third Quarter 2026 Results
Nine-month operating cash flow turned positive, while the raised annual outlook assumes lower incremental fuel and aluminum costs.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Exceeds Net Sales and Profitability Guidance
Delivers Net Sales Growth of
Raises 2026 Net Sales and Adjusted EBITDA Outlook
Third Quarter 2026 Highlights
-
Net sales grew
18.4% year over year to$48.3 million -
Gross profit margin was
46.4% , an improvement of 0.8 percentage points year over year -
Net loss was
, or$2.2 million per share to Zevia’s Class A Common stockholders, including$0.03 of non-cash equity-based compensation expense, an improvement in net loss of$1.0 million year over year$0.7 million -
Adjusted net loss was
(1)$2.1 million -
Adjusted EBITDA loss was
(1), an improvement of$0.9 million year over year$0.8 million
“Our better-than-expected third quarter results, combined with strong execution against our key focus areas and encouraging proof points across the business, reinforce our confidence in Zevia’s trajectory,” said Alexandre Ruberti, President and CEO of Zevia. “With a stronger foundation, significant liquidity and additional capital, we are entering an exciting new chapter for our business. We believe we now have the resources, momentum and strategic plan to accelerate our growth and create shareholder value over the long term.”
Third Quarter 2026 Results
Net sales increased
Gross profit margin was
Selling and marketing expenses were
Marketing expenses were
General and administrative expenses were
Equity-based compensation, a non-cash expense, was
Net loss in the third quarter of 2026 was
(1) |
Adjusted Net Loss and Adjusted EBITDA are non-GAAP financial measures. See the supplementary schedules in this press release for a discussion of how we define and calculate these measures and a reconciliation thereof to the most directly comparable GAAP measures. |
Loss per share in the third quarter of 2026 was
Adjusted net loss in the third quarter of 2026 was
Adjusted EBITDA loss was
Adjusted net loss and Adjusted EBITDA are non-GAAP financial measures. See the supplementary schedules in this press release for a discussion of how we define and calculate these measures and a reconciliation thereof to the most directly comparable GAAP measure.
Balance Sheet
As of September 30, 2026, the Company had
2026 Outlook
“We delivered a strong quarter, raised our outlook and announced a growth equity investment that strengthens our ability to accelerate our strategic reset,” said Girish Satya, Chief Financial Officer of Zevia. “With greater flexibility to invest in innovation, portfolio expansion, distribution and brand building, we believe we are well positioned to move faster against our growth priorities and capture the opportunities ahead. We remain focused on disciplined execution and creating sustainable long-term value for all shareholders and other stakeholders.”
For the full year 2026, the Company now expects net sales to be in the range of
For the fourth quarter of 2026, the Company expects net sales to be in the range of
We have not provided the forward-looking GAAP equivalent to our Adjusted EBITDA outlook or a GAAP reconciliation as a result of the uncertainty regarding, and the potential variability of, reconciling items such as equity-based compensation, income tax, certain litigation expenses, and charges associated with restructuring and cost saving initiatives, including but not limited to severance costs, warehouse/distribution facility exit costs, and asset impairments. Accordingly, a reconciliation of this non-GAAP guidance metric to its corresponding GAAP equivalent is not available without unreasonable effort. These items are inherently variable and uncertain and depend on various factors, some of which are outside of the Company’s control or ability to predict. However, it is important to note that the reconciling items could have a significant effect on future GAAP results. We have provided historical reconciliations of GAAP to non-GAAP metrics in tables at the end of this release. For more information regarding the non-GAAP financial measures discussed in this earnings release, please see “Reconciliation of GAAP to non-GAAP Financial Results” below.
Subsequent Events
Subsequent to quarter end, on October 22, 2026, the Company announced that it has entered into a definitive agreement with a fund managed by GP Investments Ltd. to issue convertible preferred stock in exchange for
Webcast
The Company will also host a conference call to discuss its results at 4:30 p.m. Eastern Time today. Investors and other interested parties may listen to the webcast of the conference call by logging on via the Investor Relations section of Zevia’s website at https://investors.zevia.com/. Those who wish to participate in the call may do so by dialing (877) 423-9813 or (201) 689-8573 for international callers, conference ID 13762906. A replay of the webcast will be available for approximately thirty (30) days following the call at Zevia’s website at https://investors.zevia.com/.
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the
About Zevia
Zevia PBC is a
(ZEVIA-F)
ZEVIA PBC |
||||||||||||||||
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED) |
||||||||||||||||
(in thousands, except share and per share amounts) |
||||||||||||||||
|
|
|
|
|
||||||||||||
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
2026 |
|
2025 |
|
2026 |
|
2025 |
||||||||
Net sales |
$ |
48,343 |
|
$ |
40,844 |
|
$ |
139,436 |
|
$ |
123,391 |
|
||||
Cost of goods sold |
|
25,902 |
|
|
22,227 |
|
|
72,680 |
|
|
64,049 |
|
||||
Gross profit |
|
22,441 |
|
|
18,617 |
|
|
66,756 |
|
|
59,342 |
|
||||
Operating expenses: |
|
|
|
|
|
|
|
|
||||||||
Selling and marketing |
|
15,145 |
|
|
12,665 |
|
|
42,742 |
|
|
41,363 |
|
||||
General and administrative |
|
8,259 |
|
|
7,673 |
|
|
25,878 |
|
|
22,733 |
|
||||
Equity-based compensation |
|
1,035 |
|
|
950 |
|
|
4,008 |
|
|
2,663 |
|
||||
Depreciation and amortization |
|
163 |
|
|
202 |
|
|
514 |
|
|
690 |
|
||||
Restructuring |
|
— |
|
|
— |
|
|
1,037 |
|
|
2,169 |
|
||||
Total operating expenses |
|
24,602 |
|
|
21,490 |
|
|
74,179 |
|
|
69,618 |
|
||||
Loss from operations |
|
(2,161 |
) |
|
(2,873 |
) |
|
(7,423 |
) |
|
(10,276 |
) |
||||
Other (expense) income, net |
|
(2 |
) |
|
(7 |
) |
|
33 |
|
|
432 |
|
||||
Loss before income taxes |
|
(2,163 |
) |
|
(2,880 |
) |
|
(7,390 |
) |
|
(9,844 |
) |
||||
(Benefit from) provision for income taxes |
|
(5 |
) |
|
(32 |
) |
|
45 |
|
|
26 |
|
||||
Net loss and comprehensive loss |
|
(2,158 |
) |
|
(2,848 |
) |
|
(7,435 |
) |
|
(9,870 |
) |
||||
Loss attributable to noncontrolling interest |
|
49 |
|
|
162 |
|
|
253 |
|
|
1,261 |
|
||||
Net loss attributable to Zevia PBC |
$ |
(2,109 |
) |
$ |
(2,686 |
) |
$ |
(7,182 |
) |
$ |
(8,609 |
) |
||||
|
|
|
|
|
|
|
|
|
||||||||
Net loss per share attributable to common stockholders |
|
|
|
|
|
|
|
|
||||||||
Basic |
$ |
(0.03 |
) |
$ |
(0.04 |
) |
$ |
(0.10 |
) |
$ |
(0.13 |
) |
||||
Diluted |
$ |
(0.03 |
) |
$ |
(0.04 |
) |
$ |
(0.10 |
) |
$ |
(0.13 |
) |
||||
|
|
|
|
|
|
|
|
|
||||||||
Weighted average common shares outstanding |
|
|
|
|
|
|
|
|
||||||||
Basic |
|
72,139,840 |
|
|
67,326,383 |
|
|
70,740,810 |
|
|
65,552,688 |
|
||||
Diluted |
|
72,139,840 |
|
|
67,326,383 |
|
|
70,740,810 |
|
|
65,552,688 |
|
||||
ZEVIA PBC |
||||||||
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) |
||||||||
(in thousands) |
||||||||
|
|
|
|
|
||||
|
|
September 30, 2026 |
|
December 31, 2025 |
||||
ASSETS |
|
|
|
|
|
|
||
Current assets: |
|
|
|
|
|
|
||
Cash and cash equivalents |
|
$ |
29,513 |
|
|
$ |
25,354 |
|
Accounts receivable, net |
|
|
10,073 |
|
|
|
11,106 |
|
Inventories |
|
|
15,142 |
|
|
|
20,393 |
|
Prepaid expenses and other current assets |
|
|
1,866 |
|
|
|
1,367 |
|
Total current assets |
|
|
56,594 |
|
|
|
58,220 |
|
Property and equipment, net |
|
|
826 |
|
|
|
867 |
|
Right-of-use assets under operating leases, net |
|
|
137 |
|
|
|
549 |
|
Intangible assets, net |
|
|
3,093 |
|
|
|
3,135 |
|
Other non-current assets |
|
|
1,980 |
|
|
|
849 |
|
Total assets |
|
$ |
62,630 |
|
|
$ |
63,620 |
|
LIABILITIES AND EQUITY |
|
|
|
|
|
|
||
Current liabilities: |
|
|
|
|
|
|
||
Accounts payable |
|
$ |
18,661 |
|
|
$ |
17,565 |
|
Accrued expenses and other current liabilities |
|
|
11,607 |
|
|
|
9,786 |
|
Current portion of operating lease liabilities |
|
|
187 |
|
|
|
668 |
|
Total current liabilities |
|
|
30,455 |
|
|
|
28,019 |
|
Total liabilities |
|
|
30,455 |
|
|
|
28,019 |
|
|
|
|
|
|
|
|
||
Stockholders’ equity |
|
|
|
|
|
|
||
Class A common stock |
|
|
71 |
|
|
|
67 |
|
Class B common stock |
|
|
6 |
|
|
|
8 |
|
Additional paid-in capital |
|
|
181,425 |
|
|
|
182,226 |
|
Accumulated deficit |
|
|
(138,444 |
) |
|
|
(131,262 |
) |
Total Zevia PBC stockholders’ equity |
|
|
43,058 |
|
|
|
51,039 |
|
Noncontrolling interests |
|
|
(10,883 |
) |
|
|
(15,438 |
) |
Total equity |
|
|
32,175 |
|
|
|
35,601 |
|
Total liabilities and equity |
|
$ |
62,630 |
|
|
$ |
63,620 |
|
ZEVIA PBC |
||||||||
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (UNAUDITED) |
||||||||
(in thousands) |
||||||||
|
|
|
||||||
|
|
Nine Months Ended September 30, |
||||||
|
|
2026 |
|
2025 |
||||
Operating activities: |
|
|
|
|
|
|
||
Net loss |
|
$ |
(7,435 |
) |
|
$ |
(9,870 |
) |
Adjustments to reconcile net loss to net cash provided by (used in) operating activities: |
|
|
|
|
|
|
||
Non-cash lease expense |
|
|
412 |
|
|
|
412 |
|
Depreciation and amortization |
|
|
514 |
|
|
|
690 |
|
Loss on disposal of property, equipment and software, net |
|
|
5 |
|
|
|
7 |
|
Amortization of debt issuance cost |
|
|
75 |
|
|
|
57 |
|
Equity-based compensation |
|
|
4,008 |
|
|
|
2,663 |
|
Changes in operating assets and liabilities: |
|
|
|
|
|
|
||
Accounts receivable, net |
|
|
1,033 |
|
|
|
(1,813 |
) |
Inventories |
|
|
5,251 |
|
|
|
4,490 |
|
Prepaid expenses and other assets |
|
|
(499 |
) |
|
|
100 |
|
Accounts payable |
|
|
1,207 |
|
|
|
(1,573 |
) |
Accrued expenses and other current liabilities |
|
|
1,375 |
|
|
|
1,124 |
|
Operating lease liabilities |
|
|
(481 |
) |
|
|
(483 |
) |
Net cash provided by (used in) operating activities |
|
|
5,465 |
|
|
|
(4,196 |
) |
Investing activities: |
|
|
|
|
|
|
||
Purchases of property, equipment and software |
|
|
(563 |
) |
|
|
(226 |
) |
Net cash used in investing activities |
|
|
(563 |
) |
|
|
(226 |
) |
Financing activities: |
|
|
|
|
|
|
||
Proceeds from exercise of stock options |
|
|
1 |
|
|
|
59 |
|
Financing costs paid |
|
|
(548 |
) |
|
|
(261 |
) |
Payment of debt issuance costs |
|
|
(195 |
) |
|
|
— |
|
Net cash used in financing activities |
|
|
(743 |
) |
|
|
(202 |
) |
Net change from operating, investing, and financing activities |
|
|
4,159 |
|
|
|
(4,624 |
) |
Cash and cash equivalents at beginning of period |
|
|
25,354 |
|
|
|
30,653 |
|
Cash and cash equivalents at end of period |
|
$ |
29,513 |
|
|
$ |
26,029 |
|
Use of Non-GAAP Financial Information
We use Adjusted Net Loss and Adjusted EBITDA, financial measures that are not calculated in accordance with
We calculate Adjusted Net Loss as net loss adjusted to exclude: (1) restructuring expenses, and (2) certain litigation expenses.
We calculate Adjusted EBITDA as net loss adjusted to exclude: (1) other (expense) (income), net, which includes interest (income) expense and foreign currency (gains) losses, (2) (benefit) from provision for income taxes, (3) depreciation and amortization, (4) equity-based compensation, (5) restructuring expenses, and (6) certain litigation expenses. Also, Adjusted EBITDA may in the future be adjusted for amounts impacting net income related to the Tax Receivable Agreement liability and other infrequent and unusual transactions.
Adjusted Net Loss and Adjusted EBITDA are presented for supplemental informational purposes only, have limitations as analytical tools and should not be considered in isolation or as a substitute for financial information presented in accordance with
In addition, our use of Adjusted Net Loss and Adjusted EBITDA may not be comparable to similarly-titled measures of other companies because they may not calculate Adjusted Net Loss and Adjusted EBITDA in the same manner, limiting their usefulness as comparative measures. Because of these limitations, when evaluating our performance, you should consider Adjusted Net Loss and Adjusted EBITDA alongside other financial measures, including our net income (loss) and other results stated in accordance with
ZEVIA PBC |
||||||||||||||||
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL RESULTS |
||||||||||||||||
(in thousands) |
||||||||||||||||
(unaudited) |
||||||||||||||||
The following table presents a reconciliation of net loss, the most directly comparable financial measure stated in accordance with GAAP, to Adjusted Net Loss for the periods presented: |
||||||||||||||||
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
(in thousands) |
|
2026 |
|
2025 |
|
2026 |
|
2025 |
||||||||
Net loss and comprehensive loss |
|
$ |
(2,158 |
) |
|
$ |
(2,848 |
) |
|
$ |
(7,435 |
) |
|
$ |
(9,870 |
) |
Restructuring |
|
|
— |
|
|
|
— |
|
|
|
1,037 |
|
|
|
2,169 |
|
Certain litigation expenses |
|
|
73 |
|
|
|
— |
|
|
|
2,435 |
|
|
|
— |
|
Adjusted Net Loss |
|
$ |
(2,085 |
) |
|
$ |
(2,848 |
) |
|
$ |
(3,963 |
) |
|
$ |
(7,701 |
) |
The following table presents a reconciliation of net loss, the most directly comparable financial measure stated in accordance with GAAP, to Adjusted EBITDA for the periods presented: |
||||||||||||||||
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
(in thousands) |
|
2026 |
|
2025 |
|
2026 |
|
2025 |
||||||||
Net loss and comprehensive loss |
|
$ |
(2,158 |
) |
|
$ |
(2,848 |
) |
|
$ |
(7,435 |
) |
|
$ |
(9,870 |
) |
Other expense (income), net* |
|
|
2 |
|
|
|
7 |
|
|
|
(33 |
) |
|
|
(432 |
) |
(Benefit from) provision for income taxes |
|
|
(5 |
) |
|
|
(32 |
) |
|
|
45 |
|
|
|
26 |
|
Depreciation and amortization |
|
|
163 |
|
|
|
202 |
|
|
|
514 |
|
|
|
690 |
|
Equity-based compensation |
|
|
1,035 |
|
|
|
950 |
|
|
|
4,008 |
|
|
|
2,663 |
|
Restructuring expenses |
|
|
— |
|
|
|
— |
|
|
|
1,037 |
|
|
|
2,169 |
|
Certain litigation expenses |
|
|
73 |
|
|
|
— |
|
|
|
2,435 |
|
|
|
— |
|
Adjusted EBITDA |
|
$ |
(890 |
) |
|
$ |
(1,721 |
) |
|
$ |
571 |
|
|
$ |
(4,754 |
) |
* Includes interest (income) expense, and foreign currency (gains) losses. |
||||||||||||||||
View source version on businesswire.com: https://www.businesswire.com/news/home/20261104093160/en/
Investors
Jean
ADDO Investor Relations
zevia@addo.com
Source: Zevia PBC